Organigram Launches Trailblazer Snax, the Largest, Competitively Priced Cannabis-Infused Chocolate Bar in Canada
July 28 2020 - 6:00AM
Business Wire
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
company of Organigram Inc. (the “Company” or “Organigram”), a
leading licensed producer of cannabis, is pleased to announce the
launch of its most recent cannabis 2.0 product Trailblazer Snax, a
premium-quality, value-priced, cannabis-infused chocolate bar.
Made with premium quality ingredients including cocoa butter,
all-natural flavors and pure distillate, Trailblazer Snax has been
developed to satisfy the most discerning chocolate connoisseurs
while remaining an affordable cannabis-infused option.
Available in both mint and mocha flavours, the 42g bar with 10mg
of THC is competitively priced and the largest cannabis-infused
chocolate bar currently available in Canada. With each bar
consisting of five sections, the Company expects it will appeal to
chocolate lovers, consumers looking to share and individuals
looking to control their dosage.
“At Organigram, it has always been our intention to not only be
a leader in the cannabis marketplace but to also continue to
disrupt it, with new products, new technology and new ways of
thinking,” says Greg Engel, CEO, Organigram. “Offering our
customers exceptional chocolate, exceptional flavour and
exceptional value is our goal.”
Organigram has made a significant investment in chocolate
innovation and product development. Organigram’s investment in
state-of-the art equipment and manufacturing processes means that
each of the five sections of the Trailblazer Snax bar are filled
separately, allowing for higher accuracy of infusion.
The Company’s $15 million investment in a high-speed,
high-capacity, fully automated production line also helped bring
Edison Bytes, premium cannabis-infused chocolate truffles, to
market earlier this year. The first shipments of the Company’s
Trailblazer Snax have headed to market and will be available
through retailers in all provinces except Quebec in the coming
weeks. Quebec does not allow the sale of cannabis-infused
chocolate.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics and Trailblazer.
Organigram's facility is located in Moncton, New Brunswick and the
Company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors that change supply quantities; customer purchasing
patterns; competitive conditions including pricing conditions;
actual retail selling prices and jurisdictions where products are
available for sale from time to time; including general risks
related to COVID-19 and risks as disclosed in the Company’s most
recent annual information form, management’s discussion and
analysis and other Company documents filed from time to time on
SEDAR (see www.sedar.com) and filed or furnished to the Securities
and Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200728005251/en/
For Investor Relations enquiries, please contact: Amy Schwalm
Vice President, Investor Relations Amy.Schwalm@organigram.ca (416)
704-9057
For Media enquiries, please contact: Marlo Taylor
mtaylor@gagecommunications.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Sep 2023 to Sep 2024